Cibus Inc
CBUS1.710USD
+0.170+11.04%
Cierre 12/19, 16:00（ET）Cotizaciones retrasadas 15 min
89.89MCap. mercado
PérdidaP/E TTM
Más Datos de Cibus Inc Compañía
Cibus, Inc. is an agricultural technology company that uses gene-editing technologies to develop plant traits in seeds. Its business is the development of plant traits for some of the agricultural food crops that help address specific productivity, profitability, sustainability, or yield challenges in farming. Its core technology propriety gene editing platform is called the Rapid Trait Development System (RTDS). It is the underlying technology in the Company's Trait Machine process, an end-to-end semi-automated high-throughput gene editing system that directly edits seed companies' elite germplasm. It has a pipeline of five productivity traits. It has developed the productivity trait Pod Shatter Reduction (PSR) in Canola and Winter Oilseed Rape (WOSR) strengthens the sheath around the canola seeds. Its advanced productivity traits, Sclerotinia resistance and HT2 in Canola and WOSR, continue to progress and offer white mold disease resistance and broadleaf weed herbicide tolerance.
Información de Cibus Inc
Símbolo de cotizaciónCBUS
Nombre de la empresaCibus Inc
Fecha de salida a bolsaJul 20, 2017
Director ejecutivoBeetham (Peter Ronald)
Número de empleados157
Tipo de seguridadOrdinary Share
Fin del año fiscalJul 20
Dirección6455 Nancy Ridge Drive
CiudadSAN DIEGO
Bolsa de valoresNASDAQ OMX - NASDAQ BASIC
PaísUnited States of America
Código postal92121
Teléfono18584500008
Sitio Webhttps://www.cibus.com/
Símbolo de cotizaciónCBUS
Fecha de salida a bolsaJul 20, 2017
Director ejecutivoBeetham (Peter Ronald)
Ejecutivos de Cibus Inc
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Rory B. Riggs
Mr. Rory B. Riggs
Chairman of the Board, Co-Founder
Chairman of the Board, Co-Founder
14.63M
+396.82%
Dr. Peter Ronald Beetham, Ph.D.
Dr. Peter Ronald Beetham, Ph.D.
President, Interim Chief Executive Officer, Co-Founder, Chief Operating Officer, Director
President, Interim Chief Executive Officer, Co-Founder, Chief Operating Officer, Director
382.44K
--
Dr. Greg Gocal, Ph.D.
Dr. Greg Gocal, Ph.D.
Co-Founder, Executive Vice President, Chief Scientific Officer
Co-Founder, Executive Vice President, Chief Scientific Officer
374.84K
+19.06%
Mr. Jason Stokes, Esq.
Mr. Jason Stokes, Esq.
Chief Legal Officer, General Counsel and Corporate Secretary
Chief Legal Officer, General Counsel and Corporate Secretary
127.67K
--
Ms. Noel Sauer, Ph.D.
Ms. Noel Sauer, Ph.D.
Senior Vice President - Research
Senior Vice President - Research
105.48K
--
Dr. Gerhard Prante, Ph.D.
Dr. Gerhard Prante, Ph.D.
Independent Director
Independent Director
40.20K
+421.56%
Ms. Kimberly Ann (Kim) Box
Ms. Kimberly Ann (Kim) Box
Director
Director
--
--
Mr. Cornelis (Carlo) Broos
Mr. Cornelis (Carlo) Broos
Chief Financial Officer
Chief Financial Officer
--
--
Mr. Craig Wichner
Mr. Craig Wichner
Director
Director
--
--
Mr. August J. Moretti, J.D.
Mr. August J. Moretti, J.D.
Independent Director
Independent Director
--
--
Ver más
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Rory B. Riggs
Mr. Rory B. Riggs
Chairman of the Board, Co-Founder
Chairman of the Board, Co-Founder
14.63M
+396.82%
Dr. Peter Ronald Beetham, Ph.D.
Dr. Peter Ronald Beetham, Ph.D.
President, Interim Chief Executive Officer, Co-Founder, Chief Operating Officer, Director
President, Interim Chief Executive Officer, Co-Founder, Chief Operating Officer, Director
382.44K
--
Dr. Greg Gocal, Ph.D.
Dr. Greg Gocal, Ph.D.
Co-Founder, Executive Vice President, Chief Scientific Officer
Co-Founder, Executive Vice President, Chief Scientific Officer
374.84K
+19.06%
Mr. Jason Stokes, Esq.
Mr. Jason Stokes, Esq.
Chief Legal Officer, General Counsel and Corporate Secretary
Chief Legal Officer, General Counsel and Corporate Secretary
127.67K
--
Ms. Noel Sauer, Ph.D.
Ms. Noel Sauer, Ph.D.
Senior Vice President - Research
Senior Vice President - Research
105.48K
--
Dr. Gerhard Prante, Ph.D.
Dr. Gerhard Prante, Ph.D.
Independent Director
Independent Director
40.20K
+421.56%
Desglose de ingresos
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2023
La empresa aún no ha revelado los datos relevantes.
Por regiónUSD
Nombre
Ganancia
Proporción
United States
933.00K
0.00%
Por negocio
Por región
La empresa aún no ha revelado los datos relevantes.
Estadísticas de accionistas
Actualizado: lun., 17 de nov
Actualizado: lun., 17 de nov
Accionistas
Tipos de accionistas
Accionistas
Accionistas
Proporción
Riggs (Rory B)
27.75%
Fidelity Management & Research Company LLC
13.93%
JPL Investments SA
3.18%
Vantage Consulting Group, Inc.
2.17%
The Vanguard Group, Inc.
1.83%
Otro
51.14%
Accionistas
Accionistas
Proporción
Riggs (Rory B)
27.75%
Fidelity Management & Research Company LLC
13.93%
JPL Investments SA
3.18%
Vantage Consulting Group, Inc.
2.17%
The Vanguard Group, Inc.
1.83%
Otro
51.14%
Tipos de accionistas
Accionistas
Proporción
Individual Investor
30.16%
Investment Advisor
17.15%
Corporation
3.25%
Investment Advisor/Hedge Fund
3.06%
Hedge Fund
0.89%
Family Office
0.21%
Research Firm
0.18%
Venture Capital
0.13%
Bank and Trust
0.10%
Otro
44.87%
Participación institucional
Actualizado: lun., 8 de dic
Actualizado: lun., 8 de dic
Periodo del informe
Número de instituciones
Acciones mantenidas
Proporción
Cambio
2025Q4
155
11.44M
29.24%
--
2025Q3
160
11.44M
29.36%
-1.15M
2025Q2
160
12.59M
24.13%
+683.12K
2025Q1
154
11.90M
30.83%
+1.84M
2024Q4
150
9.30M
35.60%
+430.74K
2024Q3
137
8.87M
33.20%
+582.16K
2024Q2
125
8.28M
27.75%
+2.07M
2024Q1
106
6.21M
28.39%
+246.00K
2023Q4
96
5.70M
24.18%
+956.24K
2023Q3
100
4.74M
25.36%
+638.98K
Ver más
Actividad de los accionistas
Nombre
Acciones mantenidas
Proporción
Cambio
Cambio %
Fecha
Riggs (Rory B)
14.63M
27.84%
+11.68M
+396.82%
Jun 09, 2025
Fidelity Management & Research Company LLC
7.17M
13.64%
+2.57M
+55.97%
Jun 30, 2025
JPL Investments SA
1.67M
3.19%
-12.28K
-0.73%
Mar 24, 2025
Vantage Consulting Group, Inc.
1.14M
2.18%
--
--
Jun 30, 2025
The Vanguard Group, Inc.
856.15K
1.63%
-35.97K
-4.03%
Jun 30, 2025
Beetham (Peter Ronald)
382.44K
0.73%
--
--
Mar 24, 2025
Gocal (Gregory Francis William)
374.84K
0.71%
+60.00K
+19.06%
Mar 24, 2025
BlackRock Institutional Trust Company, N.A.
456.21K
0.87%
-575.56K
-55.78%
Jun 30, 2025
Geode Capital Management, L.L.C.
257.74K
0.49%
-215.87K
-45.58%
Jun 30, 2025
Certior Financial Group, LLC
173.56K
0.33%
+27.21K
+18.59%
Jun 30, 2025
Ver más
ETFs relacionados
Actualizado: sáb., 6 de dic
Actualizado: sáb., 6 de dic
Nombre
Proporción
iShares Micro-Cap ETF
0.01%
iShares Russell 2000 Value ETF
0%
Global X Russell 2000 ETF
0%
Proshares Ultra Russell 2000
0%
ProShares UltraPro Russell2000
0%
ProShares Hedge Replication ETF
0%
iShares Core S&P Total U.S. Stock Market ETF
0%
iShares Russell 2000 ETF
0%
iShares Micro-Cap ETF
Proporción0.01%
iShares Russell 2000 Value ETF
Proporción0%
Global X Russell 2000 ETF
Proporción0%
Proshares Ultra Russell 2000
Proporción0%
ProShares UltraPro Russell2000
Proporción0%
ProShares Hedge Replication ETF
Proporción0%
iShares Core S&P Total U.S. Stock Market ETF
Proporción0%
iShares Russell 2000 ETF
Proporción0%
Dividendos
Un total de
0.00
USD se ha distribuido en dividendos durante los últimos 5 años.
Fecha
Dividendos
Fecha de registro
Fecha de pago
Fecha ex-dividendo
Sin datos
División de acciones
Fecha
Tipo
Relación
Jun 01, 2023
Merger
5→1
Apr 07, 2023
Merger
10→1
Fecha
Tipo
Relación
Jun 01, 2023
Merger
5→1
Apr 07, 2023
Merger
10→1
Preguntas frecuentes
¿Quiénes son los cinco principales accionistas de Cibus Inc?
Los cinco principales accionistas de Cibus Inc son:
Riggs (Rory B) posee 14.63M acciones, lo que representa el 27.84% del total de acciones.
Fidelity Management & Research Company LLC posee 7.17M acciones, lo que representa el 13.64% del total de acciones.
JPL Investments SA posee 1.67M acciones, lo que representa el 3.19% del total de acciones.
Vantage Consulting Group, Inc. posee 1.14M acciones, lo que representa el 2.18% del total de acciones.
The Vanguard Group, Inc. posee 856.15K acciones, lo que representa el 1.63% del total de acciones.
Riggs (Rory B) posee 14.63M acciones, lo que representa el 27.84% del total de acciones.
Fidelity Management & Research Company LLC posee 7.17M acciones, lo que representa el 13.64% del total de acciones.
JPL Investments SA posee 1.67M acciones, lo que representa el 3.19% del total de acciones.
Vantage Consulting Group, Inc. posee 1.14M acciones, lo que representa el 2.18% del total de acciones.
The Vanguard Group, Inc. posee 856.15K acciones, lo que representa el 1.63% del total de acciones.
¿Cuáles son los tres principales tipos de accionista de Cibus Inc?
Los tres principales tipos de accionista de Cibus Inc son:
Riggs (Rory B)
Fidelity Management & Research Company LLC
JPL Investments SA
Riggs (Rory B)
Fidelity Management & Research Company LLC
JPL Investments SA
¿Cuántas instituciones poseen acciones de Cibus Inc (CBUS)?
A fecha de 2025Q4, 155 instituciones poseen acciones de Cibus Inc, con un valor de mercado combinado de aproximadamente 11.44M, lo que representa el 29.24% del total de acciones. En comparación con el 2025Q3, el accionariado institucional ha aumentado en -0.12%.
¿Cuál es la mayor fuente de ganancias de Cibus Inc?
El FY2025Q2, el segmento empresarial -- generó la ganancia más alta para Cibus Inc, ascendiendo a -- y representando el --% de la ganancia total.
